2QIU image
Deposition Date 2007-07-05
Release Date 2008-02-26
Last Version Date 2024-11-20
Entry Detail
PDB ID:
2QIU
Keywords:
Title:
Structure of Human Arg-Insulin
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
H 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Chain IDs:A, C
Chain Length:22
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Chain IDs:B, D
Chain Length:30
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural interpretation of reduced insulin activity as seen in the crystal structure of human Arg-insulin
Biochimie 90 467 473 (2008)
PMID: 18029081 DOI: 10.1016/j.biochi.2007.09.012

Abstact

The N-terminal glycine of the A-chain in insulin is reported to be one of the residues that binds to the insulin receptor. Modifications near this region lead to variations in the biological activity of insulin. One such modification viz., an addition of an arginine at the N-terminal A-chain, was reported to possess two-thirds the activity of native insulin. The crystal structure of 2 zinc human arg (A0) insulin has been elucidated to 2A resolution to understand the mechanism of reduction in insulin activity. A conformational transition from T6 to T3R3(f) and a decrease in the surface accessibility of residues in the so called receptor binding region have been observed. The presence of arginine has also induced distortions in the A chain N-terminal helix. The subtle conformational alterations like decrease in surface accessibility, alterations in the charge surface and changes in the relative orientation of the two helices in the A chain may be responsible for the reduction in activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures